Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gan & Lee Insulin Lispro vs Humalog in T1DM
NCT04254380Phase 3Withdrawn
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Dec 2019
- Primary completion
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
A Phase 3 trial of insulin lispro in type 1 diabetes mellitus (T1D), sponsored by Gan & Lee Pharmaceuticals. Planned start Dec 2019; status: withdrawn.
02
Drugs
insulin lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04254380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04254380.